SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-008569
Filing Date
2024-01-16
Accepted
2024-01-16 16:15:59
Documents
12
Period of Report
2024-01-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d723597d8k.htm   iXBRL 8-K 23988
  Complete submission text file 0001193125-24-008569.txt   145227

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA mirm-20240111.xsd EX-101.SCH 2850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE mirm-20240111_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mirm-20240111_pre.xml EX-101.PRE 11261
6 EXTRACTED XBRL INSTANCE DOCUMENT d723597d8k_htm.xml XML 3356
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38981 | Film No.: 24535332
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)